10-Q/APeriod: Q1 FY2006

AXON ENTERPRISE, INC. Quarterly Report (Amendment) for Q1 Ended Mar 31, 2006

Filed May 19, 2006For Securities:AXON

Summary

TASER International, Inc. (now Axon Enterprise, Inc.) filed an amended 10-Q for the quarter ended March 31, 2006, primarily to correct a typographical error. The report highlights a significant increase in net sales, up 36% year-over-year to $13.9 million, driven by a recovery from negative publicity and an increase in X26 model sales and cartridge sales. Despite increased sales, the company reported a net income of $0.8 million, a substantial improvement from $5,393 in the prior year's quarter, reflecting improved gross margins due to production efficiencies. The company's liquidity remains strong with $45.4 million in cash and investments and no outstanding debt. However, the company also disclosed material weaknesses in its internal controls over financial reporting related to accounting for manufacturing overhead and financial statement preparation. Furthermore, the company faces ongoing risks from numerous product liability lawsuits, securities litigation, and an SEC investigation that has concluded without enforcement action regarding certain matters but continues for others. Investors should note the company's reliance on the TASER X26 product and the ongoing legal and regulatory challenges, balanced against improving sales and operational efficiency.

Key Highlights

  • 1Net sales increased significantly by 36% to $13.9 million in Q1 2006 compared to Q1 2005, attributed to overcoming negative publicity and increased demand for the TASER X26.
  • 2Gross margin improved to 64% of net sales from 55% in the prior year, driven by production efficiencies and lower scrap expense.
  • 3Net income rose to $0.8 million ($0.01 per share) from $5,393 ($0.00 per share) in the prior year's quarter, reflecting strong sales growth and improved margins.
  • 4The company maintains a strong liquidity position with $45.4 million in cash and investments and no outstanding debt as of March 31, 2006.
  • 5The company identified and disclosed material weaknesses in its internal control over financial reporting related to the calculation of manufacturing overhead and financial statement preparation, leading to restatements of prior periods.
  • 6TASER X26 sales and single cartridge sales showed substantial growth, indicating continued reliance on these product lines for revenue.
  • 7Despite the SEC investigation concluding without enforcement recommendations on certain matters, the company faces ongoing product liability lawsuits and securities litigation, with 48 product liability cases pending.

Frequently Asked Questions

The primary reason for the 36% increase in net sales to $13.9 million was the company's perceived recovery from negative publicity surrounding its products, which had previously caused customers, particularly law enforcement agencies, to postpone purchasing decisions. The resolution of key portions of an SEC investigation in December 2005 appears to have encouraged these agencies to proceed with their evaluation and purchasing programs.

The main concerns include material weaknesses in internal controls over financial reporting, specifically regarding the calculation of manufacturing overhead and financial statement preparation, which necessitated restatements. Additionally, the company faces significant ongoing risks from numerous product liability lawsuits (48 pending), securities litigation, and potential negative impacts from adverse publicity. The company's financial performance is also heavily reliant on the success of its TASER X26 product.

Effective January 1, 2006, the company adopted the fair value recognition provisions of SFAS 123(R) for stock-based compensation. This resulted in the recognition of $362,000 in stock-based compensation expense in the first quarter of 2006, which was not recognized in the prior year's comparable period. This adoption increased operating expenses and impacted net income.

As of March 31, 2006, TASER International had $45.4 million in cash and investments and no outstanding debt. The company also has a $10 million revolving line of credit, though no amount was outstanding under it at the end of the quarter. Management believes existing resources are adequate for at least the next 12 months, but may require additional financing for manufacturing expansion.